Nami Hagihara

Vascular protection by chloroquine during brain tumor therapy with Tf-CRM107.

Nami Hagihara, Stuart Walbridge, Alan Olson et al. · PubMed · 2000 · 65 citations

Medicine, Oncology, Pharmacology +17

Vasoactive Intestinal Polypeptide and Pituitary Adenylate Cyclase-Activating Polypeptide Receptor Chimeras Reveal Domains That Determine Specificity of Vasoactive Intestinal Polypeptide Binding and Activation

Hitoshi Hashimoto, Nobuya Ogawa, Nami Hagihara et al. · Molecular Pharmacology · 1997 · 47 citations

Life Sciences, Biochemistry, Pharmacology +17

cDNA cloning of a mouse pituitary avenylate cyclase-activating polypeptive receptor

Hitoshi Hashimoto, Kyohei Yamamoto, Nami Hagihara et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1996 · 39 citations

Life Sciences, Endocrinology, Molecular Biology +12

Mice with Markedly Reduced PACAP (PAC₁) Receptor Expression by Targeted Deletion of the Signal Peptide

Hitoshi Hashimoto, Norihito Shintani, Akiko Nishino et al. · Journal of Neurochemistry · 2000 · 37 citations

Life Sciences, Endocrinology, Molecular Biology +16

Genomic Organization and Chromosomal Location of the Mouse Vasoactive Intestinal Polypeptide 1 (VPAC1) Receptor

Hitoshi Hashimoto, Akiko Nishino, Norihito Shintani et al. · Genomics · 1999 · 24 citations

Life Sciences, Genetics, Molecular Genetics +5